Business
Perimeter Medical Imaging AI Announces First Commercial Placement of Perimeter S-Series OCT in the State of Utah
Perimeter Medical Imaging AI Announces First Commercial Placement of Perimeter S-Series OCT in th...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n \n \n \n Perimeter Medical Imaging AI Announces First Commercial Placement of Perimeter S-Series OCT in the State of Utah\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n and\n \n DALLAS\n \n \n ,\n \n \n April 25, 2023\n \n \n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (\"Perimeter\" or the \"Company\") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – announced the first commercial placement of its flagship Perimeter S-Series OCT system in the state of\n \n Utah\n \n , which will be used under the direction of breast surgeon,\n \n Jennifer J. Tittensor\n \n , MD, FACS.\n \n \n \n \n \n \n \n \n \n Perimeter S-Series OCT received FDA 510(k) clearance in 2021 and is a medical imaging tool that uses Optical Coherence Tomography (OCT) to provide clinicians with cross-sectional, real-time margin visualization (1-2 mm below the surface) of an excised tissue specimen.\n \n \n \n Jeremy Sobotta\n \n , Perimeter's Chief Executive Officer stated, \"As we continue to reach out to leading surgeons across the U.S. to educate about the benefits of our flagship Perimeter S-Series OCT, we are pleased to report this first commercial placement in\n \n Utah\n \n . The momentum continues to build in our sales pipeline, resulting in increased leads and demonstrations with key opinion leaders, like Dr. Tittensor, who represent the champions and initial adopters of our ground-breaking technology.\"\n \n \n \n Jennifer J. Tittensor\n \n , MD, FACS, \"Surgeons have long recognized the challenge of achieving 'clean' margins while preserving healthy tissue during breast conservation surgery. I believe Perimeter S-Series OCT will assist me to make informed decisions on margin status 'real-time' in the OR, with the goal of providing the best care and outcomes for my patients.\"\n \n \n \n About Perimeter Medical Imaging AI, Inc.\n \n \n \n Based in\n \n Tor...